Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome

Journal of Child Neurology

Volumn 11, Issue 4, 1996, Pages 296-300

  Lappalainen, Raija ^a   Lindholm, Dan ^b   Riikonen, Raili ^c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; RETT SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; NERVE GROWTH FACTORS; RETT SYNDROME;

EID: 0029683113     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389601100407     Document Type: Article

References (34)

1. Rett A: Über ein cerebral-atrophisches Syndrom bei Hyperammonämie. Wen, Brüder Hollinek, 1966, pp 1-68.
2. Hagberg BA, Aicardi J, Dias K, Ramos O: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases. Ann Neurol 1983;14:471-179.
3. Hagberg BA, Witt-Engerström I: Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet 1986;24:47-59.
4. Percy AK: Neurochemistry of the Rett syndrome. Brain Dev 1992;14 (Suppl):57-62.
5. Hagberg BA. Rett syndrome: Clinical peculiarities, diagnostic approach, and possible cause. Pediatr Neurol 1989;5:75-83.
6. Hagberg BA: The Rett syndrome: An introductory overview 1990. Brain Dev 1992;14(Suppl):5-8.
7. Hagberg B, Anvret M, Percy A, Wahlström J: Conclusion aspects on origin -future approach, in Hagberg B (ed): Rett Syndrome - Clinical and Biological Aspects. London, Mac Keith, 1993, pp 114-116.
8. Ebendahl T: Function and evolution in the NGF family and its receptors. J Neurosci Res 1992;32:461-470.
9. Thoenen H: The changing scene of neurotrophic factors. Trends Neurosci 1991;14:165-170.
10. Levi-Montalcini R: The nerve growth factor 35 years later. Science 1987;237:1154-1162.
11. Hefti F: Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transsections. J Neurosci 1986; 6:2155-2162.
12. Cuello AC, Garofalo L, Kenigsberg RL, et al: Degeneration and regeneration of basal forebrain cholinergic neurons, in Horrocks LA, Neff NH, Yates AJ, Hadjiconstantinou M (eds): Trophic Factors and the Nervous System. New York, Raven Press, 1990, pp 307-326.
13. Barde Y-A: Trophic factors and neuronal survival. Neuron 1989;2:1525-1534.
14. Wenk GL, O'Leary M, Nemeroff CB, et al: Neurochemical alterations in Rett syndrome. Dev Brain Res 1993;74:67-72.
15. Spranger M, Lindholm D, Bandtlow C, et al: Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: Comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci 1990;2:69-76.
16. Lindholm D, Hengerer B, Castren E: In vitro and in vivo methods for evaluating actions of cytokines on nerve growth factor production in central nervous system. Methods Neurosci 1993; 17:37-60.
17. Levi-Montalcini R, Aloe L, Alleva E: A role for nerve growth factor in nervous, endocrine and immune systems. Prog Neurol Endocrinol Immunol 1990;1:1-10.
18. Lindholm D, Heumann R, Meyer M, Thoenen H: Interleukin-1 regulates synthesis of nerve growth factor in non-neural cells of rat sciatic nerve. Nature 1987;330:658-659.
19. Bischoff SC, Dahinden CA: Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-2669.
20. Longo FM, Selak I, Zoviekian J, et al: Neurotrophic activities in cerebrospinal fluid of head trauma patients. Exp Neurol 1984; 84:207-218.
21. Patterson SL, Grady MS, Bothwell M: Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 1993;605:43-49.
22. Laudiero LB, Aloe L, Levi-Montalcini R, et al: Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992;147(1):9-12.
23. Gall CM, Isackson PJ: Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 1989;245:758-76 1.
24. Gall C, Murray K, Isackson PJ: Kainic-acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus. Mol Brain Res 1991;9:113-12 3.
25. Bengzon J, Söderström S, Kokaia Z, et al: Widespread increase of nerve growth factor protein in the rat forebrain after kindling-induced seizures. Brain Res 1992;587:338-342.
26. Alderson RF, Alterman AL, Barde Y-A, Lindsay RM: Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990;5:297-306.
27. Zafra F, Castren E, Thoenen H, Lindholm D: Interplay between glutamate and gamma-aminobutyric acid transmitter systems in physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc Natl Acad Sci U S A 1991;88:10037-10041.
28. da Penha-Berzaghi M, Cooper J, Castren E, et al: Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J Neurosci 1993;13:3818-3826.
29. Kromer LF: Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987;235:214-216.
30. Cheng B, Mattson MP: NGF and bFGF protect hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991;7:1031-1041.
31. Frim DM, Short MP, Rosenberg WS, et al: Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg 1993;78:267-273.
32. Murakami A, Tatsuno T, Kimura T, et al: Regulation of nerve growth factor secretion in L-M-cells by catechol derivatives. Neurosci Res 1993;17:71-75.
33. Olson L, Backlund E-O, Ebendal T, et al: Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: One year follow-up of first clinical trial. Arch Neurol 1991;48:373-381.
34. Friden PM, Walus LR, Watson P, et al: Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 1993;259: 373-374.